ArticleEmerging infectious diseases2010
Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies.
Article in Emerging infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics.PloS one · 2012Pooled it
- The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?Cost effectiveness and resource allocation : C/E · 2023Article
- mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia.Vaccine · 2023Article
- Feedback Between Behavioral Adaptations and Disease Dynamics.Scientific reports · 2018Article
- Early Characterization of the Severity and Transmissibility of Pandemic Influenza Using Clinical Episode Data from Multiple Populations.PLoS computational biology · 2015Article
- Buy now, saved later? The critical impact of time-to-pandemic uncertainty on pandemic cost-effectiveness analyses.Health policy and planning · 2015Article
- Activation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virus.Journal of virology · 2014Article
- A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness.BMC infectious diseases · 2014Article
- Optimized strategy for the control and prevention of newly emerging influenza revealed by the spread dynamics model.PloS one · 2014Article
- Understanding the cost-effectiveness of influenza vaccination in children: methodological choices and seasonal variability.PharmacoEconomics · 2013Article
- Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories.BMC public health · 2013Article
- Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.BMC infectious diseases · 2013Article
- The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.PloS one · 2013Article
- A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.PloS one · 2013Review
- Economic evaluations of childhood influenza vaccination: a critical review.PharmacoEconomics · 2012Review
- Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics.PloS one · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We used a hybrid transmission and economic model to evaluate the relative merits of stockpiling antiviral drugs and vaccine for pandemic influenza mitigation. In the absence of any intervention, our base-case assumptions generated a population clinical attack rate of 31.1%. For at least some parameter values, population prepandemic vaccination strategies were effective at containing an outbreak of pandemic influenza until the arrival of a matched vaccine. Because of the uncertain nature of many parameters, we used a probabilistic approach to determine the most cost-effective strategies. At a willingness to pay of >A$24,000 per life-year saved, more than half the simulations showed that a prepandemic vaccination program combined with antiviral treatment was cost-effective in Australia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.